Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

NKT cells in sepsis.

Leung B, Harris HW.

Clin Dev Immunol. 2010;2010. pii: 414650. doi: 10.1155/2010/414650. Epub 2010 Oct 4. Review.

2.

NKT cells: the culprits of sepsis?

Leung B, Harris HW.

J Surg Res. 2011 May 1;167(1):87-95. doi: 10.1016/j.jss.2010.09.038. Epub 2010 Oct 19. Review.

PMID:
21035139
3.

An expanding role for apolipoprotein E in sepsis and inflammation.

Chuang K, Elford EL, Tseng J, Leung B, Harris HW.

Am J Surg. 2010 Sep;200(3):391-7. doi: 10.1016/j.amjsurg.2009.10.017. Epub 2010 Apr 21.

4.

Apolipoprotein E-mediated immune regulation in sepsis.

Kattan OM, Kasravi FB, Elford EL, Schell MT, Harris HW.

J Immunol. 2008 Jul 15;181(2):1399-408.

5.

Natural killer T cells and atherosclerosis: form and function meet pathogenesis.

Braun NA, Covarrubias R, Major AS.

J Innate Immun. 2010;2(4):316-24. doi: 10.1159/000296915. Epub 2010 Mar 17. Review.

6.

Natural killer T cells in lipoprotein metabolism and atherosclerosis.

Getz GS, Vanderlaan PA, Reardon CA.

Thromb Haemost. 2011 Nov;106(5):814-9. doi: 10.1160/TH11-05-0336. Epub 2011 Sep 22. Review.

7.

Heparin protects against septic mortality via apoE-antagonism.

Chuang KI, Leung B, Hsu N, Harris HW.

Am J Surg. 2011 Sep;202(3):325-35. doi: 10.1016/j.amjsurg.2010.10.017. Epub 2011 Jul 8.

8.

Natural killer T cells within the liver: conductors of the hepatic immune orchestra.

Swain MG.

Dig Dis. 2010;28(1):7-13. doi: 10.1159/000282059. Epub 2010 May 7. Review.

PMID:
20460885
9.

T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.

Anantha RV, Mazzuca DM, Xu SX, Porcelli SA, Fraser DD, Martin CM, Welch I, Mele T, Haeryfar SM, McCormick JK.

Clin Exp Immunol. 2014 Nov;178(2):292-309. doi: 10.1111/cei.12404.

10.

C5a regulates NKT and NK cell functions in sepsis.

Fusakio ME, Mohammed JP, Laumonnier Y, Hoebe K, Köhl J, Mattner J.

J Immunol. 2011 Dec 1;187(11):5805-12. doi: 10.4049/jimmunol.1100338. Epub 2011 Nov 4.

11.

[The latest research advance in media involved in sepsis].

Hao Y, Geng L.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Feb;28(2):188-92. doi: 10.3760/cma.j.issn.2095-4352.2016.02.021. Chinese.

12.

CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.

Li Y, To K, Kanellakis P, Hosseini H, Deswaerte V, Tipping P, Smyth MJ, Toh BH, Bobik A, Kyaw T.

Circ Res. 2015 Jan 16;116(2):245-54. doi: 10.1161/CIRCRESAHA.116.304734. Epub 2014 Nov 14.

13.

Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.

Stevenson HL, Estes MD, Thirumalapura NR, Walker DH, Ismail N.

Am J Pathol. 2010 Aug;177(2):766-76. doi: 10.2353/ajpath.2010.091110. Epub 2010 Jul 8.

14.

Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells.

Allan LL, Hoefl K, Zheng DJ, Chung BK, Kozak FK, Tan R, van den Elzen P.

Blood. 2009 Sep 17;114(12):2411-6. doi: 10.1182/blood-2009-04-211417. Epub 2009 Jul 20.

15.

The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock.

Hu CK, Venet F, Heffernan DS, Wang YL, Horner B, Huang X, Chung CS, Gregory SH, Ayala A.

J Immunol. 2009 Feb 15;182(4):2467-75. doi: 10.4049/jimmunol.0801463.

16.

Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis.

Van Oosten M, Rensen PC, Van Amersfoort ES, Van Eck M, Van Dam AM, Breve JJ, Vogel T, Panet A, Van Berkel TJ, Kuiper J.

J Biol Chem. 2001 Mar 23;276(12):8820-4. Epub 2001 Jan 2.

17.

Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.

Kadowaki T, Morishita A, Niki T, Hara J, Sato M, Tani J, Miyoshi H, Yoneyama H, Masaki T, Hattori T, Matsukawa A, Hirashima M.

Crit Care. 2013 Dec 9;17(6):R284. doi: 10.1186/cc13147.

18.

The inflammatory response in sepsis.

Bosmann M, Ward PA.

Trends Immunol. 2013 Mar;34(3):129-36. doi: 10.1016/j.it.2012.09.004. Epub 2012 Oct 2. Review.

19.

Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.

Andoh Y, Ogura H, Satoh M, Shimano K, Okuno H, Fujii S, Ishimori N, Eshima K, Tamauchi H, Otani T, Nakai Y, Van Kaer L, Tsutsui H, Onoé K, Iwabuchi K.

Immunobiology. 2013 Apr;218(4):561-9. doi: 10.1016/j.imbio.2012.07.022. Epub 2012 Jul 27.

20.

A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.

Li Y, Kanellakis P, Hosseini H, Cao A, Deswaerte V, Tipping P, Toh BH, Bobik A, Kyaw T.

Cardiovasc Res. 2016 Feb 1;109(2):305-17. doi: 10.1093/cvr/cvv259. Epub 2015 Nov 24.

PMID:
26604037

Supplemental Content

Support Center